AIM Institute and CAN Well being Community be a part of forces to assist Canadian options attain clinicians and sufferers quicker
NEW WESTMINSTER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) — Royal Columbian Hospital Basis’s AIM Institute (Advancing Innovation in Drugs) has partnered with the CAN Well being Community to collaborate in supporting and scaling promising Canadian well being applied sciences – serving to sufferers profit sooner from made-in-Canada options.
This collaboration brings collectively two Canadian organizations with a shared dedication to strengthening affected person care by means of innovation. By aligning AIM’s scientific experience and trial infrastructure with the CAN Well being Community’s nationwide community of well being care operators and procurement pathways, the partnership is designed to assist Canadian health-tech firms transfer quicker from thought to validated resolution, and in the end to broader adoption throughout Canada.
Canadian health-tech firms will profit from entry to user-defined scientific challenges, direct engagement with frontline clinicians, rigorous scientific trial design and execution, and real-world product analysis. The aim is to make sure that new options will not be solely revolutionary, but in addition clinically validated, economically viable, and prepared for scale inside Canada’s well being care system.
As a social enterprise of Royal Columbian Hospital Basis, AIM Institute companions with health-tech innovators at each stage of growth, from early scientific steerage to multi-centre trials and real-world implementation. Its work is grounded within the perception that bettering affected person care and attaining industrial success are intrinsically linked.
The CAN Well being Community connects healthcare organizations throughout the nation by means of an built-in market to establish challenges, validate Canadian options in real-world settings, and assist procurement and scale. Since its launch in 2019, CAN Well being has supported commercialization initiatives with greater than 100 Canadian firms, serving to strengthen well being care supply whereas driving financial development.
“Working alongside the CAN Health Network allows us to help promising Canadian technologies move more efficiently from concept to real-world use,” says Dr. Steve Reynolds, Royal Columbian Hospital ICU doctor and AIM Government Lead. “This helps ensure that solutions developed here can ultimately improve care for patients and support healthcare teams across the country and beyond.”
“The most powerful health care solutions come from solving real problems faced by patients and providers,” said Dante Morra, Founder & CEO, CAN Health Network. “By connecting innovators with frontline health care environments through the AIM Institute, we can test, validate and scale Canadian solutions faster, improving care while helping Canadian companies grow and succeed.”
This partnership between AIM and CAN Health establishes a framework for the two organizations to identify opportunities, align clinical and operational expertise, and accelerate the evaluation and adoption of innovative technologies.
By connecting clinical insight, rigorous evaluation, and national pathways for adoption, the partnership aims to strengthen Canada’s health innovation ecosystem while ensuring that patients, providers and the broader economy benefit.
About Royal Columbian Hospital
As BC’s most comprehensive critical care hospital, one in three British Columbians rely on Royal Columbian Hospital. We are the only hospital in BC with trauma, cardiac, neurosciences, high-risk obstetrics and neonatal intensive care on one site. We look after some of the most seriously ill and injured patients, and we do it with the support of donors like you.
Since 1978, donors to Royal Columbian Hospital Foundation have helped fund priority equipment needs, facility enhancements, research, education and innovation at Royal Columbian Hospital. Visit rchfoundation.com for more information.
As part of Royal Columbian Hospital Foundation, the AIM Institute is a social enterprise that partners with innovative health-tech companies, providing clinical insights grounded in deep expertise, alongside clinical trial design and execution.
About the CAN Health Network
The Coordinated Accessible National (CAN) Health Network is a federally supported, not-for-profit organization that works with health care operators across Canada to identify challenges, validate Canadian innovations in real-world settings, and support procurement and scale. Since its launch in 2019, CAN Health has supported commercialization projects with more than 100 Canadian companies, helping strengthen health care delivery while driving economic growth.